Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label,Phase Two Study to Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa

NCT00827996 is registered in ClinicalTrials.gov with Florida Academic Dermatology Centers as lead sponsor.

NCT NCT00827996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00827996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label,Phase Two Study to Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa
Lead sponsor
Florida Academic Dermatology Centers
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2007
Completion date
August 31, 2008
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa